Oppenheimer Downgrades Prestige Consumer Healthcare (PBH)
Prestige Consumer Healthcare Inc PBH
$46.75
▲ +1.79%
(+$0.82)
Index member:
S&P/TSX Composite
Open
$46.39
Prev Close
$45.93
Day Range
$46.04 – $48.41
52W Range
$42.62 – $89.37
Market Cap
$2.45B
P/E (TTM)
11.65
Beta
0.36
EPS (TTM)
$3.78
📋 Company Profile
| Industry | Pharmaceuticals |
| Sector | Consumer Staples |
| Country | US |
| Exchange | NEW YORK STOCK EXCHANGE, INC. |
| Currency | USD |
| IPO Date | 2005-02-10 |
| Shares Out. | 47,320,000 |
| Website | prestigebrands.com/ ↗ |
| Phone | 19145246800 |
Prestige Consumer Healthcare Inc is a publicly traded company under the ticker symbol PBH on the NEW YORK STOCK EXCHANGE, INC., operating in the Pharmaceuticals industry. Quotes and metrics shown here are sourced from public market data and refreshed regularly.
📊 Analyst Ratings
10 analysts (2026-05-01)
📰 Latest News for PBH
Prestige Consumer Healthcare Inc. (PBH) Q4 2026 Earnings Call Transcript
Oppenheimer Downgrades Prestige Consumer to Perform
Prestige Consumer Healthcare Inc. 2026 Q4 - Results - Earnings Call Presentation
Transcript : Prestige Consumer Healthcare Inc., Q4 2026 Earnings Call, May 14, 2026
Transcript: Prestige Consumer Q4 2026 Earnings Conference Call
Prestige Consumer Healthcare: Fiscal Q4 Earnings Snapshot
Prestige Consumer Healthcare : Q4 2026 Prestige Consumer Healthcare Inc. Earnings Conference Call Presentation